Global and China Drugs for Short Bowel Syndrome Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Drugs for Short Bowel Syndrome industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Merck

    • Ardelyx

    • Takeda

    • Nutrinia

    • Emmaus Medical

    • Sancilio Pharmaceuticals

    • Zealand Pharma

    • OxThera

    • Naia Pharmaceuticals

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • GLP-2

    • Growth Hormone

    • Glutamine

    • Others

    Application:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Drugs for Short Bowel Syndrome Industry Overview

      • 1.1.1 Drugs for Short Bowel Syndrome Market Scope and Market Segments

      • 1.1.2 Drugs for Short Bowel Syndrome Industry Characteristics

      • 1.1.3 Global and China Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Drugs for Short Bowel Syndrome Production Value and Growth Rate (2017-2028)

    • 1.2 Global Drugs for Short Bowel Syndrome Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 GLP-2

      • 1.2.2 Growth Hormone

      • 1.2.3 Glutamine

      • 1.2.4 Others

    • 1.3 Global Drugs for Short Bowel Syndrome Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital Pharmacies

      • 1.3.2 Retail Pharmacies

      • 1.3.3 Online Pharmacies

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Drugs for Short Bowel Syndrome Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Drugs for Short Bowel Syndrome Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Drugs for Short Bowel Syndrome Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Drugs for Short Bowel Syndrome Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Drugs for Short Bowel Syndrome Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Drugs for Short Bowel Syndrome Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Drugs for Short Bowel Syndrome Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Drugs for Short Bowel Syndrome Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Drugs for Short Bowel Syndrome Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Drugs for Short Bowel Syndrome Industry Porter's Five Forces Model Analysis

      • 2.2.3 Drugs for Short Bowel Syndrome Industry PEST Analysis

    • 2.3 Drugs for Short Bowel Syndrome Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Drugs for Short Bowel Syndrome Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Drugs for Short Bowel Syndrome Industry

    Chapter 3 Global and China Drugs for Short Bowel Syndrome Market, by Manufacturer

    • 3.1 Global and China Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Drugs for Short Bowel Syndrome Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Drugs for Short Bowel Syndrome Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Drugs for Short Bowel Syndrome Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Drugs for Short Bowel Syndrome Market Top 3 Players

    Chapter 4 Global and China Drugs for Short Bowel Syndrome Market, by Type (2017-2028)

    • 4.1 Drugs for Short Bowel Syndrome Market Trend, by Type

    • 4.2 Global Drugs for Short Bowel Syndrome Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Drugs for Short Bowel Syndrome Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Drugs for Short Bowel Syndrome Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Drugs for Short Bowel Syndrome Price Trend, by Type (2017-2028)

    • 4.3 China Drugs for Short Bowel Syndrome Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Drugs for Short Bowel Syndrome Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Drugs for Short Bowel Syndrome Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Drugs for Short Bowel Syndrome Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Drugs for Short Bowel Syndrome Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Drugs for Short Bowel Syndrome Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Drugs for Short Bowel Syndrome Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Drugs for Short Bowel Syndrome Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Drugs for Short Bowel Syndrome Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Drugs for Short Bowel Syndrome Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Drugs for Short Bowel Syndrome Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Drugs for Short Bowel Syndrome Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Drugs for Short Bowel Syndrome Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Drugs for Short Bowel Syndrome Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Drugs for Short Bowel Syndrome Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Drugs for Short Bowel Syndrome Market Analysis

    • 7.1 North America Drugs for Short Bowel Syndrome Market, by Type

    • 7.2 North America Drugs for Short Bowel Syndrome Market, by Application

    • 7.3 North America Drugs for Short Bowel Syndrome Market Analysis and Forecast, by Country

      • 7.3.1 United States Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Drugs for Short Bowel Syndrome Market Analysis

    • 8.1 Europe Drugs for Short Bowel Syndrome Market, by Type

    • 8.2 Europe Drugs for Short Bowel Syndrome Market, by Application

    • 8.3 Europe Drugs for Short Bowel Syndrome Market Analysis and Forecast, by Country

      • 8.3.1 Germany Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Drugs for Short Bowel Syndrome Market Analysis

    • 9.1 APAC Drugs for Short Bowel Syndrome Market, by Type

    • 9.2 APAC Drugs for Short Bowel Syndrome Market, by Application

    • 9.3 APAC Drugs for Short Bowel Syndrome Market Analysis and Forecast, by Country

      • 9.3.1 China Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Drugs for Short Bowel Syndrome Market Analysis

    • 10.1 Latin America, Middle East and Africa Drugs for Short Bowel Syndrome Market, by Type

    • 10.2 Latin America, Middle East and Africa Drugs for Short Bowel Syndrome Market, by Application

    • 10.3 Latin America, Middle East and Africa Drugs for Short Bowel Syndrome Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Drugs for Short Bowel Syndrome Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Drugs for Short Bowel Syndrome Company Profiles

      • 11.1 Merck

        • 11.1.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Merck Drugs for Short Bowel Syndrome Product Profiles, Application and Specification

        • 11.1.3 Merck Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Ardelyx

        • 11.2.1 Ardelyx Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Ardelyx Drugs for Short Bowel Syndrome Product Profiles, Application and Specification

        • 11.2.3 Ardelyx Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Takeda

        • 11.3.1 Takeda Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Takeda Drugs for Short Bowel Syndrome Product Profiles, Application and Specification

        • 11.3.3 Takeda Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Nutrinia

        • 11.4.1 Nutrinia Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Nutrinia Drugs for Short Bowel Syndrome Product Profiles, Application and Specification

        • 11.4.3 Nutrinia Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Emmaus Medical

        • 11.5.1 Emmaus Medical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Emmaus Medical Drugs for Short Bowel Syndrome Product Profiles, Application and Specification

        • 11.5.3 Emmaus Medical Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Sancilio Pharmaceuticals

        • 11.6.1 Sancilio Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Sancilio Pharmaceuticals Drugs for Short Bowel Syndrome Product Profiles, Application and Specification

        • 11.6.3 Sancilio Pharmaceuticals Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Zealand Pharma

        • 11.7.1 Zealand Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Zealand Pharma Drugs for Short Bowel Syndrome Product Profiles, Application and Specification

        • 11.7.3 Zealand Pharma Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 OxThera

        • 11.8.1 OxThera Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 OxThera Drugs for Short Bowel Syndrome Product Profiles, Application and Specification

        • 11.8.3 OxThera Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Naia Pharmaceuticals

        • 11.9.1 Naia Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Product Profiles, Application and Specification

        • 11.9.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Drugs for Short Bowel Syndrome Industry Investment Prospect and Risk Assessment

    • 12.1 Drugs for Short Bowel Syndrome Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Drugs for Short Bowel Syndrome Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure China Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure Global Drugs for Short Bowel Syndrome Production Value and Growth Rate (2017-2028)

    • Figure China Drugs for Short Bowel Syndrome Production Value and Growth Rate (2017-2028)

    • Figure Global Drugs for Short Bowel Syndrome Market Size and Growth Rate of GLP-2 (2017-2028)

    • Figure Global Drugs for Short Bowel Syndrome Market Size and Growth Rate of Growth Hormone (2017-2028)

    • Figure Global Drugs for Short Bowel Syndrome Market Size and Growth Rate of Glutamine (2017-2028)

    • Figure Global Drugs for Short Bowel Syndrome Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Drugs for Short Bowel Syndrome Market Size and Growth Rate of Hospital Pharmacies (2017-2028)

    • Figure Global Drugs for Short Bowel Syndrome Market Size and Growth Rate of Retail Pharmacies (2017-2028)

    • Figure Global Drugs for Short Bowel Syndrome Market Size and Growth Rate of Online Pharmacies (2017-2028)

    • Figure North America Drugs for Short Bowel Syndrome Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Drugs for Short Bowel Syndrome Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Drugs for Short Bowel Syndrome Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Drugs for Short Bowel Syndrome Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Drugs for Short Bowel Syndrome Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Drugs for Short Bowel Syndrome Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Drugs for Short Bowel Syndrome Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Drugs for Short Bowel Syndrome Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Drugs for Short Bowel Syndrome Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Drugs for Short Bowel Syndrome Market Share, by Manufacturer in 2021

    • Figure Global and China Drugs for Short Bowel Syndrome Market Share, by Manufacturer in 2022

    • Table Global Drugs for Short Bowel Syndrome Sales Volume, by Type (2017-2028)

    • Table Global Drugs for Short Bowel Syndrome Sales Volume Share, by Type (2017-2028)

    • Figure Global Drugs for Short Bowel Syndrome Sales Volume Share, by Type (2017-2028)

    • Table Global Drugs for Short Bowel Syndrome Sales Value, by Type (2017-2028)

    • Table Global Drugs for Short Bowel Syndrome Sales Value Share, by Type (2017-2028)

    • Figure Global Drugs for Short Bowel Syndrome Price Trend, by Type (2017-2028)

    • Table China Drugs for Short Bowel Syndrome Sales Volume, by Type (2017-2028)

    • Table China Drugs for Short Bowel Syndrome Sales Volume Share, by Type (2017-2028)

    • Figure China Drugs for Short Bowel Syndrome Sales Volume Share, by Type (2017-2028)

    • Table China Drugs for Short Bowel Syndrome Sales Value, by Type (2017-2028)

    • Table China Drugs for Short Bowel Syndrome Sales Value Share, by Type (2017-2028)

    • Figure China Drugs for Short Bowel Syndrome Price Trend, by Type (2017-2028)

    • Table Global Drugs for Short Bowel Syndrome Sales Volume, by Application (2017-2028)

    • Table Global Drugs for Short Bowel Syndrome Sales Volume Share, by Application (2017-2028)

    • Figure Global Drugs for Short Bowel Syndrome Sales Volume Share, by Application (2017-2028)

    • Table Global Drugs for Short Bowel Syndrome Sales Value, by Application (2017-2028)

    • Table Global Drugs for Short Bowel Syndrome Sales Value Share, by Application (2017-2028)

    • Figure Global Drugs for Short Bowel Syndrome Sales Value Share, by Application (2017-2028)

    • Table China Drugs for Short Bowel Syndrome Sales Volume, by Application (2017-2028)

    • Table China Drugs for Short Bowel Syndrome Sales Volume Share, by Application (2017-2028)

    • Figure China Drugs for Short Bowel Syndrome Sales Volume Share, by Application (2017-2028)

    • Table China Drugs for Short Bowel Syndrome Sales Value, by Application (2017-2028)

    • Table China Drugs for Short Bowel Syndrome Sales Value Share, by Application (2017-2028)

    • Figure China Drugs for Short Bowel Syndrome Sales Value Share, by Application (2017-2028)

    • Figure China Drugs for Short Bowel Syndrome Production, Import, Consumption and Export (2017-2022)

    • Figure North America Drugs for Short Bowel Syndrome Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Drugs for Short Bowel Syndrome Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Drugs for Short Bowel Syndrome Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Drugs for Short Bowel Syndrome Production, Import, Consumption and Export (2017-2022)

    • Table North America Drugs for Short Bowel Syndrome Sales Volume, by Type (2017-2028)

    • Table North America Drugs for Short Bowel Syndrome Sales Volume Share, by Type (2017-2028)

    • Figure North America Drugs for Short Bowel Syndrome Sales Volume Share, by Type (2017-2028)

    • Table North America Drugs for Short Bowel Syndrome Sales Volume, by Application (2017-2028)

    • Table North America Drugs for Short Bowel Syndrome Sales Volume Share, by Application (2017-2028)

    • Figure North America Drugs for Short Bowel Syndrome Sales Volume Share, by Application (2017-2028)

    • Figure United States Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure United States Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure Canada Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Table Europe Drugs for Short Bowel Syndrome Sales Volume, by Type (2017-2028)

    • Table Europe Drugs for Short Bowel Syndrome Sales Volume Share, by Type (2017-2028)

    • Figure Europe Drugs for Short Bowel Syndrome Sales Volume Share, by Type (2017-2028)

    • Table Europe Drugs for Short Bowel Syndrome Sales Volume, by Application (2017-2028)

    • Table Europe Drugs for Short Bowel Syndrome Sales Volume Share, by Application (2017-2028)

    • Figure Europe Drugs for Short Bowel Syndrome Sales Volume Share, by Application (2017-2028)

    • Figure Germany Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure UK Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure UK Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure France Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure France Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure Italy Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure Spain Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure Poland Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure Russia Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Table APAC Drugs for Short Bowel Syndrome Sales Volume, by Type (2017-2028)

    • Table APAC Drugs for Short Bowel Syndrome Sales Volume Share, by Type (2017-2028)

    • Figure APAC Drugs for Short Bowel Syndrome Sales Volume Share, by Type (2017-2028)

    • Table APAC Drugs for Short Bowel Syndrome Sales Volume, by Application (2017-2028)

    • Table APAC Drugs for Short Bowel Syndrome Sales Volume Share, by Application (2017-2028)

    • Figure APAC Drugs for Short Bowel Syndrome Sales Volume Share, by Application (2017-2028)

    • Figure China Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure China Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure Japan Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure India Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure India Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Drugs for Short Bowel Syndrome Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Drugs for Short Bowel Syndrome Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Drugs for Short Bowel Syndrome Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Drugs for Short Bowel Syndrome Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Drugs for Short Bowel Syndrome Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Drugs for Short Bowel Syndrome Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Drugs for Short Bowel Syndrome Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Drugs for Short Bowel Syndrome Sales Value and Growth Rate (2017-2028)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ardelyx Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ardelyx Product Profiles, Application and Specification

    • Table Ardelyx Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takeda Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takeda Product Profiles, Application and Specification

    • Table Takeda Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nutrinia Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nutrinia Product Profiles, Application and Specification

    • Table Nutrinia Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Emmaus Medical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Emmaus Medical Product Profiles, Application and Specification

    • Table Emmaus Medical Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sancilio Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sancilio Pharmaceuticals Product Profiles, Application and Specification

    • Table Sancilio Pharmaceuticals Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Zealand Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Zealand Pharma Product Profiles, Application and Specification

    • Table Zealand Pharma Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table OxThera Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table OxThera Product Profiles, Application and Specification

    • Table OxThera Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Naia Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Naia Pharmaceuticals Product Profiles, Application and Specification

    • Table Naia Pharmaceuticals Drugs for Short Bowel Syndrome Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.